{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:00:30Z","timestamp":1787313630447,"version":"build-2736575974"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Among patients with inflammatory bowel disease (IBD), the risk of thromboembolism (TE) is increased, representing a relevant cause of morbidity and mortality. In contrast to other extraintestinal IBD manifestations, TE receives much less attention because of its low incidence, estimated at merely 0.4\u20130.9% in hospitalised children with IBD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cases with TE, as documented in the German-Austrian Paediatric IBD registry gesellschaft f\u00fcr p\u00e4diatrische gastroenterologie und ern\u00e4hrung \u2013 large paediatric patient registry (CEDATA-GPGE), were analyzed retrospectively. For all patients with signs of TE, a questionnaire was filled in by the treating paediatric gastroenterologist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Over 10 years, 4,153 paediatric patients with IBD (0\u201318 years) were registered in the registry, and 12 of them identified with TE. Eight patients were diagnosed with ulcerative colitis (UC), three with Crohn\u2019s disease (CD), and one with IBD-unclassified. The median age at IBD diagnosis was 10 years and at the manifestation of TE 13 years, respectively, with a median latency to TE of 2 years. Prevalence of TE was 0.3%, with a significantly higher risk for patients with UC than CD (OR 5.9, CI 1.56\u201322.33,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.008). More girls than boys were affected (f:m = 7:5) without reaching significance. Approximately 90% of patients experienced TE during active disease, with relevant cerebral and limb involvement in 6\/12 patients. Various risk factors, e.g., hospitalisation, coagulopathy, or anaemia were identified. TE management included intensive care and surgery. Among the 12 patients, 11 recovered fully, in which one patient has focal epilepsy as a sequela.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Paediatric patients with IBD have a substantially increased risk for TE. Risk factors, such as those identified should be considered when managing paediatric IBD and preventive measures for those hospitalised taken routinely. Initiating pharmacological thromboprophylaxis is challenging for the lack of published trials on efficacy and safety in paediatric IBD but should be considered carefully in each case.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2022.883183","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T04:36:03Z","timestamp":1654230963000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Occurrence of Thromboembolism in Paediatric Patients With Inflammatory Bowel Disease: Data From the CEDATA-GPGE Registry"],"prefix":"10.3389","volume":"10","author":[{"given":"Jan","family":"De Laffolie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Ballauff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Blueml","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Risto","family":"Rommel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Cla\u00dfen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Laa\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almuthe Christina","family":"Hauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the CEDATA-GPGE Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/gut.2003.025411","article-title":"Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?","volume":"53","author":"Miehsler","year":"2004","journal-title":"Gut."},{"key":"B2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/ibd.21334","article-title":"Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention.","volume":"17","author":"Zitomersky","year":"2011","journal-title":"Inflamm Bowel Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/ibd.21113","article-title":"Cerebral thromboembolic events in pediatric patients with inflammatory bowel disease.","volume":"16","author":"Barclay","year":"2010","journal-title":"Inflamm Bowel Dis."},{"key":"B4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archinte.1936.00170110025002","article-title":"Extensive arterial and venous thrombosis complicating chronic ulcerative colitiS.","volume":"58","author":"Bargen","year":"1936","journal-title":"Arch Intern Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/MPG.0000000000003078","article-title":"Venous thromboembolism in pediatric inflammatory bowel disease: a case-control study.","volume":"72","author":"Mitchel","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/00005176-198911000-00012","article-title":"Neurovascular and thromboembolic complications of inflammatory bowel disease in childhood.","volume":"9","author":"Lloyd-Still","year":"1989","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/0883073807308706","article-title":"Inflammatory bowel disease and cerebrovascular arterial and venous thromboembolic events in 4 pediatric patients: a case series and review of the literature.","volume":"23","author":"Standridge","year":"2008","journal-title":"J Child Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e737S","DOI":"10.1378\/chest.11-2308","article-title":"Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines.","volume":"141","author":"Monagle","year":"2012","journal-title":"Chest."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7247238","article-title":"Comprehensive review and update on the pathogenesis of inflammatory bowel disease.","volume":"2019","author":"Guan","year":"2019","journal-title":"J Immunol Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000171464","article-title":"Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn\u2018s disease and ulcerative colitis): a review.","volume":"12","author":"Brynskov","year":"1994","journal-title":"Dig Dis."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-015-0044-2","article-title":"Thrombosis in inflammatory bowel diseases: what\u2018s the link?","volume":"13","author":"Giannotta","year":"2015","journal-title":"Thromb J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2169\/internalmedicine.46.0237","article-title":"Activations of coagulation and fibrinolysis secondary to bowel inflammation in patients with ulcerative colitis.","volume":"46","author":"Kume","year":"2007","journal-title":"Intern Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/0016-5085(94)90741-2","article-title":"Platelets circulate in an activated state in inflammatory bowel disease.","volume":"106","author":"Collins","year":"1994","journal-title":"Gastroenterology."},{"key":"B14","doi-asserted-by":"crossref","first-page":"13863","DOI":"10.3748\/wjg.v20.i38.13863","article-title":"Inflammatory bowel disease and thromboembolism.","volume":"20","author":"Zezos","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1023\/a:1005541028045","article-title":"Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis.","volume":"45","author":"Vecchi","year":"2000","journal-title":"Dig Dis Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1097\/00042737-200507000-00008","article-title":"Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease.","volume":"17","author":"Mahmood","year":"2005","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/0016-5085(95)90197-3","article-title":"Inherited disorders of coagulation appear to protect against inflammatory bowel disease.","volume":"108","author":"Thompson","year":"1995","journal-title":"Gastroenterology."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1016\/j.jpedsurg.2020.02.020","article-title":"The incidence of venous thromboembolism in children following colorectal resection for inflammatory bowel disease: a multi-center study.","volume":"55","author":"Bence","year":"2020","journal-title":"J Pediatr Surg."},{"key":"B19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jss.2019.04.087","article-title":"Risk Factors for venous thromboembolism in children and young adults with inflammatory bowel disease.","volume":"243","author":"McKie","year":"2019","journal-title":"J Surg Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/MPG.0000000000001690","article-title":"Pediatric gastroenterologists\u2019 approach to venous thromboembolism prophylaxis in pediatric inflammatory bowel disease.","volume":"66","author":"Chien","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/gut.2010.228585","article-title":"Thromboembolic risk among danish children and adults with inflammatory bowel diseases: a population-based nationwide study.","volume":"60","author":"Kappelman","year":"2011","journal-title":"Gut."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/ecco-jcc\/jjab113","article-title":"Inflammatory bowel disease increases the risk of venous thromboembolism in children: a population-based matched cohort study.","volume":"15","author":"Kuenzig","year":"2021","journal-title":"J Crohns Colitis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1002\/ibd.21563","article-title":"Thromboembolism in pediatric inflammatory bowel disease: systematic review.","volume":"17","author":"Lazzerini","year":"2011","journal-title":"Inflamm Bowel Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1160\/TH04-04-0207","article-title":"Systemic thromboembolism in children. data from the 1-800-NO-CLOTS consultation service.","volume":"92","author":"Kuhle","year":"2004","journal-title":"Thromb Haemost."},{"key":"B25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/MPG.0b013e3182801e43","article-title":"Venous thrombotic events in hospitalized children and adolescents with inflammatory bowel disease.","volume":"56","author":"Nylund","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1111\/j.1572-0241.2008.02052.x","article-title":"Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients.","volume":"103","author":"Nguyen","year":"2008","journal-title":"Am J Gastroenterol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study.","volume":"375","author":"Grainge","year":"2010","journal-title":"Lancet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e222","DOI":"10.1097\/MCG.0000000000001578","article-title":"Venous thromboembolism among patients with inflammatory bowel diseases is not related to increased thrombophilia: a case-control study.","volume":"56","author":"Ollech","year":"2022","journal-title":"J Clin Gastroenterol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.693927","article-title":"Risk factors of venous thromboembolism in inflammatory bowel disease: a systematic review and meta-analysis.","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Med (Lausanne)."},{"key":"B30","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/003655200750023589","article-title":"Inflammatory bowel disease promotes venous thrombosis earlier in life.","volume":"35","author":"Grip","year":"2000","journal-title":"Scand J Gastroenterol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1053\/j.gastro.2010.05.026","article-title":"Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.","volume":"139","author":"Novacek","year":"2010","journal-title":"Gastroenterology."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072115","article-title":"Venous thromboembolism in patients with inflammatory bowel disease: the role of pharmacological therapy and surgery.","volume":"9","author":"Papa","year":"2020","journal-title":"J Clin Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e446","DOI":"10.1055\/s-0040-1721735","article-title":"Anticoagulation for patients with venous thromboembolism: when is extended treatment required?","volume":"4","author":"Weitz","year":"2020","journal-title":"TH Open."},{"key":"B34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11239-015-1311-6","article-title":"The epidemiology of venous thromboembolism.","volume":"41","author":"Heit","year":"2016","journal-title":"J Thromb Thrombolysis."},{"key":"B35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1572-0241.2003.04026.x","article-title":"Venous thromboembolism in inflammatory bowel disease.","volume":"99","author":"Solem","year":"2004","journal-title":"Am J Gastroenterol."},{"key":"B36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/MPG.0000000000002035","article-title":"Management of paediatric ulcerative colitis, part 1: ambulatory care-an evidence-based guideline from european crohn\u2019s and colitis organization and European society of paediatric gastroenterology, hepatology and nutrition.","volume":"67","author":"Turner","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1097\/MIB.0000000000000310","article-title":"Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing.","volume":"21","author":"Papa","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092753","article-title":"Thromboprophylaxis for hospitalized patients with inflammatory bowel disease-are we there yet?","volume":"9","author":"Levartovsky","year":"2020","journal-title":"J Clin Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1093\/ibd\/izaa337","article-title":"Inflammatory bowel disease and risk of major bleeding during anticoagulation for venous thromboembolism.","volume":"27","author":"Scharrer","year":"2021","journal-title":"Inflamm Bowel Dis."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.883183\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T04:36:08Z","timestamp":1654230968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.883183\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":39,"alternative-id":["10.3389\/fped.2022.883183"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.883183","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,3]]},"article-number":"883183"}}